Eli Lilly And Co Stock Price, News & Analysis (NYSE:LLY)

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co announced a quarterly dividend on Tuesday, June 18th. Investors of record on Thursday, August 15th will be given a dividend of $0.645 per share on Tuesday, September 10th. This represents a $2.58 annualized dividend and a yield of 2.37%. The ex-dividend date is Wednesday, August 14th. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) released its quarterly earnings data on Tuesday, July, 30th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.45 by $0.05. The company had revenue of $5.64 billion for the quarter, compared to analyst estimates of $5.59 billion. Eli Lilly And Co had a return on equity of 70.86% and a net margin of 33.76%. The firm's quarterly revenue was up .9% on a year-over-year basis. During the same period in the previous year, the firm earned $1.48 earnings per share. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co will be holding an earnings conference call on Wednesday, October 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Eli Lilly And Co issued an update on its FY19 earnings guidance on Tuesday, July, 30th. The company provided earnings per share guidance of $5.67-5.77 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.66. The company issued revenue guidance of $22-22.5 billion, compared to the consensus revenue estimate of $22.18 billion.

15 Wall Street analysts have issued 12 month price objectives for Eli Lilly And Co's stock. Their predictions range from $106.00 to $143.00. On average, they anticipate Eli Lilly And Co's share price to reach $127.60 in the next twelve months. This suggests a possible upside of 17.4% from the stock's current price. View Analyst Price Targets for Eli Lilly And Co.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

News coverage about LLY stock has trended somewhat positive on Monday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Eli Lilly And Co earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a decrease in short interest during the month of September. As of September 30th, there was short interest totalling 12,190,000 shares, a decrease of 9.8% from the August 30th total of 13,510,000 shares. Based on an average daily trading volume, of 3,610,000 shares, the days-to-cover ratio is currently 3.4 days. Currently, 1.4% of the company's stock are sold short. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Pfizer (PFE), Novartis (NVS), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AstraZeneca (AZN), Sanofi (SNY), AbbVie (ABBV), GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMY), Commonwealth Bank of Australia (CSLLY), Celgene (CELG) and Bayer (BAYRY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Intel (intc), AT&T (T), Bank of America (BAC), Verizon Communications (VZ), General Electric (GE), Exxon Mobil (XOM) and JPMorgan Chase & Co. (JPM).

Eli Lilly And Co's stock is owned by a number of of retail and institutional investors. Top institutional investors include Lilly Endowment Inc. (12.08%), Robeco Institutional Asset Management B.V. (0.13%), Gateway Investment Advisers LLC (0.05%), Assenagon Asset Management S.A. (0.04%), Nisa Investment Advisors LLC (0.04%) and Bedel Financial Consulting Inc. (0.04%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Daniel Skovronsky, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Atalanta Sosnoff Capital LLC, Lilly Endowment Inc., Ferguson Wellman Capital Management Inc., Gateway Investment Advisers LLC, Pennsylvania Trust Co, Varma Mutual Pension Insurance Co, Verde Servicos Internacionais S.A. and CIBC Private Wealth Group LLC. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Robeco Institutional Asset Management B.V., Fulton Breakefield Broenniman LLC, State of Alaska Department of Revenue, Private Capital Advisors Inc., Country Trust Bank, First National Bank of Mount Dora Trust Investment Services and Envestnet Asset Management Inc.. Company insiders that have bought Eli Lilly And Co stock in the last two years include Daniel Skovronsky, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $108.64.

Eli Lilly And Co has a market capitalization of $104.88 billion and generates $24.56 billion in revenue each year. The company earns $3.23 billion in net income (profit) each year or $5.55 on an earnings per share basis. Eli Lilly And Co employs 38,680 workers across the globe.View Additional Information About Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]